{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:10:37Z","timestamp":1787026237337,"version":"build-2736575974"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Due to their special molecular weight and pharmacokinetic\/pharmacodynamic (PK\/PD) characteristics, antibody drugs have difficulty crossing the body barrier and entering complex microenvironments to provide effective treatment for encephalopathy, cancer, and severe infectious diseases. With the development and application of nanotechnology, drugs can be modified by nanomethods to increase the delivery efficiency, targeting, and permeability, reduce the resistance to the antibody, and improve the response rate, thus increasing their safety and effectiveness. Therefore, nanoparticles have extensive research and application value in drug delivery systems. This article summarizes the characteristics of nanoparticles and nanoantibody delivery systems to provide a reference for the future application of nanoparticles in drug delivery.<\/jats:p>","DOI":"10.3389\/fbioe.2026.1759915","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:44:10Z","timestamp":1770273850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Application of nanoparticles in antibody drug delivery"],"prefix":"10.3389","volume":"14","author":[{"given":"Wumiti","family":"Xiefukaiti","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Dolkun","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XueJun","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Xinjiang Medical University","place":["Urumqi, China"]},{"name":"Institute of Materia Medica, Xinjiang Medical University","place":["Urumqi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166326","DOI":"10.1016\/j.bbadis.2021.166326","article-title":"Targeted regulation of autophagy using nanoparticles: new insight into cancer therapy","volume":"1868","author":"Abad Paskeh","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-020-03403-z","article-title":"Nano-clays as potential pseudo-antibodies for COVID-19","volume":"15","author":"Abduljauwad","year":"2020","journal-title":"Nanoscale Res. Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"120416","DOI":"10.1016\/j.ijpharm.2021.120416","article-title":"Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy","volume":"599","author":"Akanda","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jconrel.2012.11.007","article-title":"Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells","volume":"165","author":"Altintas","year":"2013","journal-title":"J. Control Release"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.043","article-title":"Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches","volume":"68","author":"Anselmo","year":"2015","journal-title":"Biomaterials"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1166\/jbn.2021.3201","article-title":"Nano-drug delivery systems: possible end to the rising threats of tuberculosis","volume":"17","author":"Bashir","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1007\/s00216-016-9585-x","article-title":"VHH antibodies: emerging reagents for the analysis of environmental chemicals","volume":"408","author":"Bever","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.3390\/ijms22105188","article-title":"A nano-emulsion platform functionalized with a fully human scFv-Fc antibody for atheroma targeting: towards a Theranostic approach to atherosclerosis","volume":"22","author":"Bonnet","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/03602532.2020.1758713","article-title":"Nano-Hydroxyapatite use in dentistry: a systematic review","volume":"52","author":"Bordea","year":"2020","journal-title":"Drug Metab. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1039\/d1bm01002f","article-title":"Antibody-functionalized theranostic protein nanoparticles for the synergistic deep red fluorescence imaging and multimodal therapy of ovarian cancer","volume":"14","author":"Borlan","year":"2021","journal-title":"Biomater. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9816","DOI":"10.1039\/d0nr08191d","article-title":"The conjugation strategy affects antibody orientation and targeting properties of nanocarriers","volume":"13","author":"Br\u00fcckner","year":"2021","journal-title":"Nanoscale"},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/jpm12030353","article-title":"Comparison of Adalimumab to other targeted therapies in rheumatoid arthritis: results from systematic literature review and meta-analysis","volume":"12","author":"Cacciapaglia","year":"2022","journal-title":"J. Pers. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2147\/IJN.S244849","article-title":"Paclitaxel-Loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy","volume":"15","author":"Cao","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/pharmaceutics12111013","article-title":"Overcoming the blood-brain barrier: functionalised chitosan nanocarriers","volume":"12","author":"Caprifico","year":"2020","journal-title":"Pharmaceutics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3748\/wjg.v28.i7.755","article-title":"Crohn's disease-related 'gastrocnemius myalgia syndrome' successfully treated with infliximab: a case report","volume":"28","author":"Catherine","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ebiom.2018.03.008","article-title":"Plectin-1 targeted dual-modality nanoparticles for pancreatic cancer imaging","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.14133\/j.cnki.1008-9357.20190430001","article-title":"Application of peptide-based nanoformulations for targeting and regulating tumor microenvironment","volume":"32","author":"Chen","year":"2019","journal-title":"J. Funct. Polym."},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1039\/c9bm01580a","article-title":"The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents","volume":"8","author":"Chen","year":"2020","journal-title":"Biomater. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1021\/acs.bioconjchem.8b00667","article-title":"Half-Chain cetuximab nanoconjugates allow multitarget therapy of triple negative breast cancer","volume":"29","author":"Colombo","year":"2018","journal-title":"Bioconjug Chem."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3791\/62889","article-title":"Synthesis and characterization of mRNA-Loaded Poly(Beta aminoesters) nanoparticles for vaccination purpose","volume":"13","author":"Cristina","year":"2021","journal-title":"J. Vis. Exp."},{"key":"B21","doi-asserted-by":"publisher","first-page":"141-160","DOI":"10.1517\/17425255.2012.643868","article-title":"Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?","volume":"8","author":"Deng","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1038\/ncomms4065","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/14737140.2018.1535315","article-title":"Nivolumab for the treatment of hepatocellular carcinoma","volume":"18","author":"Finkelmeier","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.1080\/21655979.2021.2006568","article-title":"Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy","volume":"12","author":"Gao","year":"2021","journal-title":"Bioengineered"},{"key":"B26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A monoclonal antibody for malaria prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3-13","DOI":"10.1016\/j.dmpk.2018.11.002","article-title":"Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development","volume":"34","author":"Glassman","year":"2019","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"100599","DOI":"10.1016\/j.pmatsci.2019.100599","article-title":"Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy","volume":"107","author":"Guo","year":"2020","journal-title":"Prog. Mater. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1021\/acs.nanolett.1c02899","article-title":"Alkyl-Terminated gold nanoparticles as a self-therapeutic treatment for psoriasis","volume":"21","author":"Han","year":"2021","journal-title":"Nano Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41467-021-27610-z","article-title":"A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo","volume":"13","author":"Hanke","year":"2022","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"103277","DOI":"10.1016\/j.retram.2021.103277","article-title":"A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2","volume":"69","author":"Hassani","year":"2021","journal-title":"Curr. Res. Transl. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"681062","DOI":"10.3389\/fimmu.2021.681062","article-title":"Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases","volume":"12","author":"Horwitz","year":"2021","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9541","DOI":"10.1039\/d0nr00308e","article-title":"Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles","volume":"12","author":"Hossaini Nasr","year":"2020","journal-title":"Nanoscale"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.ymthe.2021.05.004","article-title":"A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19","volume":"29","author":"Idris","year":"2021","journal-title":"Mol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.actbio.2019.01.011","article-title":"Oriented immobilization to nanoparticles enhanced the therapeutic efficacy of antibody drugs","volume":"86","author":"Iijima","year":"2019","journal-title":"Acta Biomater."},{"key":"B37","doi-asserted-by":"publisher","first-page":"110337","DOI":"10.1016\/j.biopha.2020.110337","article-title":"Monoclonal antibody as a potential anti-COVID-19","volume":"129","author":"Jahanshahlu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41467-021-21497-6","article-title":"Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/fon-2017-0436","article-title":"Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma","volume":"14","author":"Joshi","year":"2018","journal-title":"Future Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ddtec.2016.09.004","article-title":"Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies","author":"Kamath","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.7150\/thno.57510","volume":"11","author":"Katerina","year":"2021","journal-title":"Theranostics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/J.ARABJC.2017.05.011","article-title":"Nanoparticles: properties, applications and Toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arabian J. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection(2021)","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4103\/jcrt.JCRT_1290_16","article-title":"Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma","volume":"14","author":"Koppolu","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jconrel.2020.11.057","article-title":"Learning from past failures: challenges with monoclonal antibody therapies for COVID-19","volume":"329","author":"Lai","year":"2021","journal-title":"J. Control Release"},{"key":"B47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.actbio.2018.04.023","article-title":"Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery","volume":"73","author":"Li","year":"2018","journal-title":"Acta Biomater."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1021\/acs.accounts.9b00167","article-title":"Functional DNA molecules enable selective and stimuli-responsive nanoparticles for biomedical applications","volume":"52","author":"Li","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1166\/jnn.2021.18664","article-title":"Preparation of Anti toll-like Receptor-4 nano-antibody and its effect on gram negative sepsis","volume":"21","author":"Liao","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.beha.2019.05.002","article-title":"Novel monoclonal antibody-based therapies for acute myeloid leukemia","volume":"32","author":"Linde","year":"2019","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/1346-8138.16185","article-title":"Autophagy in skin barrier and immune-related skin diseases","volume":"48","author":"Liu","year":"","journal-title":"J. Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1697","DOI":"10.1002\/wnan.1697","article-title":"Nanobody-A versatile tool for cancer diagnosis and therapeutics","volume":"13","author":"Liu","year":"","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-21621-4_1","article-title":"Introduction to Nanotechnology (NT) and nanomaterials (NMs)","volume":"116","author":"Madkour","year":"2019","journal-title":"Adv. Struct. Mater."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fbioe.2022.1056162","article-title":"On the quest of reliable 3D dynamic in vitro blood-brain barrier models using polymer hollow fiber membranes: pitfalls, progress, and future perspectives","volume":"22","author":"Mantec\u00f3n-Oria","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14712598.2019.1646721","article-title":"Pembrolizumab for the treatment of cervical cancer","volume":"19","author":"Marret","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.4103\/1673-5374.336132","article-title":"Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration","volume":"17","author":"Martinez","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.121.055866","article-title":"Nano-miR-133a replacement therapy blunts pressure overload-induced heart failure","volume":"144","author":"Modica","year":"2021","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","article-title":"A review on nano-based drug delivery System for cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nanomicro Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/IJN.S198353","article-title":"Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1021\/acsnano.1c01845","article-title":"Nano-Enabled COVID-19 vaccines: meeting the challenges of durable antibody plus cellular immunity and immune escape","volume":"15","author":"Nel","year":"2021","journal-title":"ACS Nano"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/infdis\/jiab265","article-title":"Monoclonal antibody requires immunomodulation for efficacy against Acinetobacter baumannii infection","volume":"224","author":"Nielsen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2174\/1570163816666190620111652","article-title":"Nanoparticles and its implications in HIV\/AIDS therapy","volume":"17","author":"Oti","year":"2020","journal-title":"Curr. Drug Discov. Technol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"540\u2043552","DOI":"10.1111\/cts.12567","article-title":"Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development","volume":"11","author":"Ovacik","year":"2018","journal-title":"Clin. Transl. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms23010131","article-title":"The application of nanoparticles in diagnosis and treatment of kidney diseases","volume":"23","author":"Paluszkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12122\/j.issn.1673-4254.2022.01.03","article-title":"Targeted killing of CD133+ lung cancer stem cells using paclitaxel-loaded PLGA-PEG nanoparticles with CD133 aptamers","volume":"42","author":"Pang","year":"2022","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(21)00440-2","article-title":"IL17A\/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study","volume":"397","author":"Papp","year":"2021","journal-title":"Lancet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"NucleosideModified mRNA vaccines induce potent T follicular helper and Germinal Center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j","article-title":"Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery","volume":"147","author":"Parodi","year":"2021","journal-title":"Biomaterials"},{"key":"B70","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4143\/crt.2016.091","article-title":"Blocking Interleukin-4 receptor \u03b1 using polyethylene glycol functionalized superparamagnetic iron oxide nanocarriers to inhibit breast cancer cell proliferation","volume":"9","author":"Pasha Shaik","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"B71","doi-asserted-by":"publisher","first-page":"56753","DOI":"10.1021\/acsami.0c17102","article-title":"In situ surface modification of microfluidic blood-brain-barriers for improved screening of small molecules and nanoparticles","volume":"212","author":"Peng","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/humupd\/dmaa049","article-title":"Nanoparticles in pregnancy: the next frontier in reproductive therapeutics","volume":"27","author":"Pritchard","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"B73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12951-021-00875-8","article-title":"Low-dose X-ray enhanced tumor accumulation of theranostic nanoparticles for high-performance bimodal imaging-guided photothermal therapy","volume":"19","author":"Qiaolin","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/psp4.12224","article-title":"Research progress and application of monoclonal antibody pharmacokinetics","volume":"40","author":"Ranchi","year":"2019","journal-title":"Shanghai Pharmaceutical"},{"key":"B75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"B76","doi-asserted-by":"publisher","first-page":"745429","DOI":"10.3389\/fphar.2021.745429","article-title":"Mechanism of miR-30b-5p-Loaded PEG-PLGA nanoparticles for targeted treatment of heart failure","volume":"30","author":"Ren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2025","journal-title":"Nat. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer\u2019s disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J. Control. Release."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0140-6736(21)00873-4","article-title":"Nanobody cytokine blockers in psoriasis","volume":"397","author":"Rubel","year":"2021","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.tranon.2021.101265","article-title":"Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells","volume":"15","author":"Saha","year":"2022","journal-title":"Transl. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"CD011535","DOI":"10.1002\/14651858.CD011535.pub3","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"12","author":"Sbidian","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"462806","DOI":"10.1016\/j.chroma.2022.462806","article-title":"Design of an integrated continuous downstream process for acid-sensitive monoclonal antibodies based on a calcium-dependent Protein A ligand","volume":"1664","author":"Scheffel","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"26332","DOI":"10.1038\/srep26332","article-title":"Cross-linked composite gel polymer electrolyte using mesoporous methacrylate-functionalized SiO2 nanoparticles for lithium-ion polymer batteries","volume":"6","author":"Shin","year":"2016","journal-title":"Sci. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/14737140.2018.1480942","article-title":"Nivolumab for the treatment of colorectal cancer","volume":"18","author":"Smith","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/antib8020038","article-title":"Super potent bispecific Llama VHH antibodies neutralize HIV via a combination of Gp41 and Gp120 epitopes","volume":"8","author":"Strokappe","year":"2019","journal-title":"Antibodies"},{"key":"B88","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jconrel.2021.05.004","article-title":"Nanobodies as efficient drug-carriers: progress and trends in chemotherapy","volume":"334","author":"Surendra Panikar","year":"2021","journal-title":"J. Control. Release"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0168621","DOI":"10.1128\/JVI.01686-21","article-title":"Establishment of a monoclonal antibody against human NTCP that blocks hepatitis B virus infection","volume":"96","author":"Takemori","year":"2022","journal-title":"J. Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/dna.2021.0457","article-title":"Clonal wars: monoclonal antibodies against infectious pathogens","volume":"41","author":"Tan","year":"2022","journal-title":"DNA Cell Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijpharm.2016.02.012","article-title":"Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells","volume":"501","author":"Tarvirdipour","year":"2016","journal-title":"Int. J. Pharm."},{"key":"B92","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2174\/1566523220999201230205126","article-title":"Gene therapy based on lipid nanoparticles as non-viral vectors for glioma treatment","volume":"21","author":"Tavares Luiz","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.2147\/IJN.S246322","article-title":"Silica nanocapsules with different sizes and physicochemical properties as suitable nanocarriers for uptake in T-Cells","volume":"15","author":"Thiramanas","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/mi9110565","article-title":"Zero-dimensional, onedimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices","volume":"57","author":"Tiwari","year":"2012","journal-title":"Prog"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.5599\/admet.2988","article-title":"Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies","volume":"13","author":"Vargas","year":"2025","journal-title":"ADMET DMPK"},{"key":"B98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11899-021-00612-w","article-title":"An update on the clinical evaluation of antibody-based therapeutics in Acute Myeloid leukemia","volume":"16","author":"Venugopal","year":"2021","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"B99","doi-asserted-by":"publisher","first-page":"103699","DOI":"10.1016\/j.ebiom.2021.103699","article-title":"Wheatley. Current and future nanoparticle vaccines for COVID-19","volume":"74","author":"Vu","year":"2021","journal-title":"EBioMedicine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","article-title":"Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments","volume":"192","author":"Wan","year":"2019","journal-title":"Biomaterials"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe","article-title":"A novel electrochemical IL-6 sensor based on Au nanoparticles-modified platinum carbon electrode","volume":"16","author":"Wang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.actbio.2018.03.029","article-title":"BaTiO 3-core Au-shell nanoparticles for photothermal therapy and bimodal imaging","volume":"72","author":"Wang","year":"2018","journal-title":"Acta Biomater."},{"key":"B103","doi-asserted-by":"publisher","first-page":"14512","DOI":"10.1002\/anie.202102044","article-title":"pH-Amplified CRET nanoparticles for in vivo imaging of tumor metastatic lymph nodes","volume":"21","author":"Wang","year":"","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ygeno.2021.05.006","article-title":"Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, South Africa, and other COVID-19-devastated countries","volume":"113","author":"Wang","year":"","journal-title":"Genomics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12951-021-01233-4","article-title":"CRISPR\/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy","volume":"20","author":"Wang","year":"","journal-title":"J. Nanobiotechnology"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s13346-021-01105-2","article-title":"Ratiometric co-delivery of doxorubicin and paclitaxel prodrug by remote-loading liposomes for the treatment of triple-negative breast cancer","volume":"12","author":"Wang","year":"","journal-title":"Drug Deliv. Transl. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.2147\/IJN.S332279","article-title":"Efficient delivery of antibodies intracellularly by Co-Assembly with hexahistidine-metal assemblies (HmA)","volume":"16","author":"Wei","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.phrs.2021.105833","article-title":"Synthesized nanoparticles, biomimetic nanoparticles and extracellular vesicles for treatment of autoimmune disease: Comparison and prospect","volume":"172","author":"Wen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B109","unstructured":"Coronavirus (COVID-19) dashboard\n          \n          \n          2022"},{"key":"B110","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/21691401.2019.1699821","article-title":"c(RGDyk)-modified nanoparticles encapsulating quantum dots as a stable fluorescence probe for imaging-guided surgical resection of glioma under the auxiliary UTMD","volume":"48","author":"Wu","year":"2020","journal-title":"Artif. Cells Nanomed Biotechnol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41467-022-28279-8","article-title":"Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10787-021-00866-z","article-title":"Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress","volume":"29","author":"Zeeshan","year":"2021","journal-title":"Inflammopharmacology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2003937","DOI":"10.1002\/advs.202003937","article-title":"Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges","volume":"8","author":"Zhang W","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1038\/s41598-017-10486-9","article-title":"Transferrin-navigation Nano artificial antibody fluorescence recognition of circulating tumor cells","volume":"31","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3389\/fimmu.2018.02202","article-title":"Genetic removal of the CH1 exon enables the production of heavy chain-only IgG in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1021\/acsnano.9b09998","article-title":"MicroRNA-125a-Loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring Effector\/Regulatory T cells balance","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"B117","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.2147\/IJN.S329831","article-title":"Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective","volume":"16","author":"Zhang J","year":"2021","journal-title":"Int. J. Nanomedicine"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1759915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:44:13Z","timestamp":1770273853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1759915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":117,"alternative-id":["10.3389\/fbioe.2026.1759915"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1759915","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1759915"}}